Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: The BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI)

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 4, 2008, Pages 319-325

  Armann, Berthold ^a   Ludermann C ^a   Ruckert R ^a   Lawall, H ^b   Liesenfeld, B ^c   Schneider, M ^d   Schmidt Lucke, J ^a  

^a Innere Abteilung   (Germany)

^b Klinikum Karlsbad Langensteinbach   (Germany)

^c KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^d Stiftungsklinikum Mittelrhein   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Bone marrow transplantation; Critical limb ischemia; Major amputation

Indexed keywords

ADULT; ANGIOGENESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE DENSITY; CANCER INCIDENCE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; GERMANY; HUMAN; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB PERFUSION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MINOR SURGERY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; WOUND HEALING; AMPUTATION; AUTOTRANSPLANTATION; BLOOD FLOW; BONE MARROW TRANSPLANTATION; CONVALESCENCE; CRITICAL ILLNESS; ISCHEMIA; LIMB; METHODOLOGY; MORTALITY; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; TIME; TREATMENT OUTCOME; VASCULARIZATION; WALKING;

AMPUTATION; BONE MARROW TRANSPLANTATION; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; EXTREMITIES; GERMANY; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; QUALITY OF LIFE; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; RESEARCH DESIGN; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WALKING; WOUND HEALING;

EID: 69949103028     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.4.319     Document Type: Article

References (24)

1. Bartsch T, Brehm M, Zeus T, Kögler G, Wernet P, Strauer BE. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study). Clin Res Cardiol 2007; 96: 891-9.
2. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; S5: 9-15.
3. Dillingham TR, Pezzinn LE, Mackenzie EJ. Limb amputation and limb deficiency. Epidemiology and recent trends in the United States. South Med J 2002; 95: 875-83.
4. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 2006; 44: 732-9.
5. Faglia E, Clerici G, Clerissi J, Gabrielli L, Losa S, Mantero M, Caminiti M, Curci V, Lupattelli T, Morabito A. Early and fiveyear amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg 2006; 32: 484-90.
6. Grundmann S, Piek JJ, Pasterkamp G, Hoefer IE. Arteriogenesis: basic mechanisms and therapeutic stimulation.Eur J Clin Invest 2007; 37: 755-66.
7. Heil M, Eitenmüller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell Mol Med 2006; 10: 45-55.
8. Hermann PC, Huber SL, Herrler T, von Hesler C, Andrassy J, Kevy SV, Jacobson MS, Heeschen C. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant 2008; 16: 1059-69.
9. Hernandez P, Cortina L, Artaza H, Pol N, Lam RM, Dorticos E, Macias C, Hernandez C, Del Valle L, Blanco A, Martinez A, Diaz F. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia:A comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2007; 194: e52-6.
10. Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-42.
11. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, Kojima H, Iwasaka T. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-25.
12. Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, Iida J, Sakata H, Onodera K, Tamaki T, Furui H, Kukita K, Meguro J, Yonekawa M, Tanaka S. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006; 9: 226-33.
13. Kinnaird T, Stabile E, Burnett MS, Epstein SE. Bone Marrow-Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences. Circ Res 2004; 95; 354-63.
14. Lachmann N, Nikol S. Therapeutic angiogenesis for peripheral artery disease: Stem cell therapy.VASA 2007; 36: 241-51.
15. Nikol S. Therapeutic angiogenesis for peripheral artery disease: Gene therapy. VASA 2007; 36: 165-73.
16. Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol 2005; 63: 351-60; discussion 361.
17. Reike H. Wundheilung und lokale Wundbehandlung bei diabetischem Fußsyndrom. Internist 1999; 40: 1009-17.
18. Risse A. Phänomenologie und Diabetologie. In:Risse A. Phänomenologische und psychopathologische Aspekte in der Diabetologie. Berlin: De Gruyter, 1998: 42-8.
19. Stellos K, Gawaz M. Platelet interaction with progenitor cells: Potential implications for regenerative medicine. Thromb Haemost 2007; 98: 922-9.
20. TASC Working Group and the Society for Vascular Surgery, The North American Chapter of the International Society for Cardiovascular Surgery, The European Society for Vascular Surgery, The International Union of Angiology. TransAtlantic Inter-Society Consensus (TASC):Management of Peripheral Arterial Disease (PAD). J Vasc Surg 2000; 31: 1-296.
21. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
22. Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, Van Bockel JH, Lindeman JH. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino) 2008; 49: 51-8.
23. Wagner FW. The dysvascular foot: a system of diagnosis and treatment. Foot Ankle 1981; 2: 64-7.
24. Wahlberg E. Angiogenesis and arteriogenesis in limb ischemia. J Vasc Surg 2003; 38: 198-203.